22 Clinical Trials for: Drug: placebo of cilostazol, Page 1 of Results

1
Recruiting
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Condition(s): Brain Ischemia; Intracranial Hemorrhages
2
Completed
Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction.
Condition(s): Cerebral Infarction
3
Completed
Overcome Biochemical Aspirin Resistance Through Cilostazol Combination
Condition(s): Cerebral Infarction
4
Active, not recruiting
Post-Marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
Condition(s): Cerebral Infarction
5
Completed
Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
Condition(s): Cerebral Infarction; Atherosclerosis
6
Recruiting
Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
Condition(s): Diabetes Mellitus, Type 2; Metabolic Syndrome X
7
Completed
Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent
Condition(s): Coronary Artery Disease
8
Completed
The Use of Cilostazol in Patients With Diabetic Nephropathy
Condition(s): Diabetes Mellitus, Type 2; Diabetes Complications
9
Completed
Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease
Condition(s): Intermittent Claudication
10
Recruiting
Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler
Condition(s): Cerebral Infarction
11
Not yet recruiting
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention
Condition(s): Angioplasty, Transluminal, Percutaneous Coronary
12
Completed
Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo
Condition(s): Healthy
13
Recruiting
Evaluation of Cilostazol in Combination With L-Carnitine
Condition(s): Peripheral Vascular Disease; Intermittent Claudication; Peripheral Arterial Disease
14
Active, not recruiting
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
Condition(s): Intermittent Claudication
15
Recruiting
Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)
Condition(s): Therapy
16
Completed
Mixed Antagonist of Serotonin for Claudication Optimal Therapy
Condition(s): Intermittent Claudication
17
Completed
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
Condition(s): Polyneuropathy
18
Completed
The Efficacy of CILostazol ON Ischemic Complications After DES Implantation
Condition(s): Coronary Artery Disease
19
Active, not recruiting
Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
Condition(s): Atherosclerosis Cerebral Infarction
20
Active, not recruiting
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
Condition(s): Type 2 Diabetes Mellitus; Arteriosclerosis Obliterans

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

Page 1 of Clinical Trials for Drug: placebo of cilostazol, 22 Total Matches

Clinical Trials Authorship and Review